[
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corporation (EW): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Edwards Lifesciences Corporation on Natan’s Substack. In this article, we will summarize the bulls’ thesis on EW. Edwards Lifesciences Corporation’s share was trading at $76.05 as of September 15th. EW’s trailing and forward P/E were 31.82 and 28.17 respectively according to Yahoo Finance. Edwards Lifesciences, the global leader in heart […]",
    "url": "https://finnhub.io/api/news?id=368071f4139da0fae743ac72b7067c6fe3ffab4267d220cdd08023d0feffb9e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758315752,
      "headline": "Edwards Lifesciences Corporation (EW): A Bull Case Theory",
      "id": 136823660,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Edwards Lifesciences Corporation on Natan’s Substack. In this article, we will summarize the bulls’ thesis on EW. Edwards Lifesciences Corporation’s share was trading at $76.05 as of September 15th. EW’s trailing and forward P/E were 31.82 and 28.17 respectively according to Yahoo Finance. Edwards Lifesciences, the global leader in heart […]",
      "url": "https://finnhub.io/api/news?id=368071f4139da0fae743ac72b7067c6fe3ffab4267d220cdd08023d0feffb9e4"
    }
  }
]